J&J raises U.S. prices on around two dozen drugs

Johnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among its top-selling products.

Study details how high fiber diets make for healthier lives

People who eat lots of high-fiber and whole grain foods have lower risk of heart disease, stroke, diabetes and other chronic diseases than people whose diets are low in fiber, a study commissioned by the World Health Organization (WHO) says.

U.S. health care industry spends $30 billion a year on marketing

(Reuters Health) – Spending on health care advertising in the U.S. has almost doubled over the past two decades as companies compete for their share of the world’s biggest health care market, a U.S. study suggests.

Program helps seniors continue to live independently

(Reuters Health) – A program that combines home modifications with specialized counseling may help seniors disabled by aging stay in their homes longer, a new study suggests.

More nurses providing primary care where MDs in short supply

(Reuters Health) – A growing number of nurse practitioners are providing primary care in rural and low-income U.S. communities where the physician workforce is shrinking, a new study suggests.